Groowe Groowe / Newsroom / ALDX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ALDX News

Aldeyra Therapeutics, Inc.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out

accessnewswire.com
ALDX

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Connect

accessnewswire.com
ALDX

Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

accessnewswire.com
ALDX

Form 8-K

sec.gov
ALDX

Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors

businesswire.com
ALDX

Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

businesswire.com
ALDX

Pomerantz LLP Advises Shareholders of Class Action Filing Involving Pomerantz LLP – ALDX

accessnewswire.com
ALDX

Pomerantz LLP Notifies Shareholders of Lawsuit Filed Against Aldeyra Therapeutics, Inc. – ALDX

accessnewswire.com
ALDX

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

businesswire.com
ALDX

ALDX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026

businesswire.com
ALDX